The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Open accessAbstract
OBJECTIVE: Accumulating evidence links the intestinal microbiota and colorectal carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and inhibit T cell-mediated immune responses against colorectal tumours. Thus, we hypothesised that the amount of F. nucleatum in colorectal carcinoma might be associated with worse clinical outcome. DESIGN: We used molecular pathological epidemiology database of 1069 rectal and colon cancer cases in the Nurses' Health Study and the Health Professionals Follow-up Study, and measured F. nucleatum DNA in carcinoma tissue. Cox proportional hazards model was used to compute hazard ratio (HR), controlling for potential confounders, including microsatellite instability (MSI, mismatch repair deficiency), CpG island methylator phenotype (CIMP), KRAS, BRAF, and PIK3CA mutations, and LINE-1 hypomethylation (low-level methylation). RESULTS: Compared with F. nucleatum-negative cases, multivariable HRs (95% CI) for colorectal cancer-specific mortality in F. nucleatum-low cases and F. nucleatum-high cases were 1.25 (0.82 to 1.92) and 1.58 (1.04 to 2.39), respectively, (p for trend=0.020). The amount of F. nucleatum was associated with MSI-high (multivariable odd ratio (OR), 5.22; 95% CI 2.86 to 9.55) independent of CIMP and BRAF mutation status, whereas CIMP and BRAF mutation were associated with F. nucleatum only in univariate analyses (p<0.001) but not in multivariate analysis that adjusted for MSI status. CONCLUSIONS: The amount of F. nucleatum DNA in colorectal cancer tissue is associated with shorter survival, and may potentially serve as a prognostic biomarker. Our data may have implications in developing cancer prevention and treatment strategies through targeting GI microflora by diet, probiotics and antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Self-citationGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationGarrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,080
Self-citationSystemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Cited by
Sorted by citations
Items 301–400 of 1,000
Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management
Rejali, L., Asl, R. S., Sanjabi, F., Fatemi, N., Aghdaei, H. A., Niasar, M. S., Moghadam, P. K., Mojarad, E. N., Mini, E., & Nobili, S. (2023) · Cancers · doi:10.3390/cancers15102746 · Cited by 50
Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy
Brockmueller, A., de Porras, V. R., & Shakibaei, M. (2024) · Phytotherapy Research · doi:10.1002/ptr.8220 · Cited by 45
Yan, X., Ma, F., Chen, Q., Gou, X., Li, X., Zhang, L., & Gao, H. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137605 · Cited by 44
Chen, J., Zhang, P., Zhao, Y., Zhao, J., Wu, X., Zhang, R., Cha, R., Yao, Q., & Gao, Y. (2022) · Science Advances · doi:10.1126/sciadv.add2789 · Cited by 43
Hui, B., Zhou, C., Xu, Y., Wang, R., Dong, Y., Zhou, Y., Ding, J., Zhang, X., Xu, J. M., & Gu, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02331-9 · Cited by 42
Conde‐Pérez, K., Aja‐Macaya, P., Buetas, E., Trigo‐Tasende, N., Nasser‐Ali, M., Rumbo‐Feal, S., Nión, P., Arribas, E. M., Estévez, L. S., Otero‐Alén, B., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13604 · Cited by 44
Duizer, C., Salomons, M., van Gogh, M., Gräve, S., Schaafsma, F. A., Stok, M. J., Sijbranda, M., Sivasamy, R. K., Willems, R. J. L., & de Zoete, M. R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2458203 · Cited by 42
Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer
Okuda, S., Shimada, Y., Tajima, Y., Yuza, K., Hirose, Y., Ichikawa, H., Nagahashi, M., Sakata, J., Ling, Y., Miura, N., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.049 · Cited by 43
Kashyap, S., Pal, S., Chandan, G., Saini, V., Chakrabarti, S., Saini, N. K., Mittal, A., Thakur, V. K., Saini, A. K., & Saini, R. V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.020 · Cited by 39
Abdullah, M., Sukartini, N., Nursyirwan, S. A., Pribadi, R. R., Maulahela, H., Utari, A. P., Muzellina, V. N., Wiraatmadja, A., & Renaldi, K. (2021) · Digestion · doi:10.1159/000516689 · Cited by 43
Fernández, J., Redondo-Blanco, S., Miguélez, E. M., Villar, C. J., Clemente, A., & Lombó, F. (2015) · AIMS Microbiology · doi:10.3934/microbiol.2015.1.48 · Cited by 41
Kosumi, K., Mima, K., Baba, H., & Ogino, S. (2018) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2018.09.05 · Cited by 43
Self-citationJanati, A. I., Karp, I., Laprise, C., Sabri, H., & Emami, E. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01526-z · Cited by 42
Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum
Despins, C. A., Brown, S. D., Robinson, A. V., Mungall, A. J. J., Allen‐Vercoe, E., & Holt, R. A. (2021) · mBio · doi:10.1128/mbio.02062-21 · Cited by 40
Nagakubo, D., & Kaibori, Y. (2023) · Microorganisms · doi:10.3390/microorganisms11092307 · Cited by 70
Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
Chen, Y., Lu, Y., Ke, Y., & Li, Y. (2019) · Medicine · doi:10.1097/md.0000000000017221 · Cited by 42
Zhu, G., Cheng, Z., Lin, C., Hoffman, R. M., Huang, Y., Singh, S. R., ZHENG, W., Yang, S., & Ye, J. (2019) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20145 · Cited by 40
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
Tarashi, S., Siadat, S. D., Badi, S. A., Zali, M. R., Biassoni, R., Ponzoni, M., & Moshiri, A. (2019) · Microorganisms · doi:10.3390/microorganisms7110561 · Cited by 39
Hertel, J., Heinken, A., Martinelli, F., & Thiele, I. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1915673 · Cited by 39
Hsieh, Y., Kuo, W.-L., Hsu, W.-T., Tung, S., & Li, C. (2022) · Cancers · doi:10.3390/cancers15010269 · Cited by 38
Ungvari, Z. I., Fekete, M., Fekete, J. T., Grosso, G., Ungvari, A., & Győrffy, B. (2024) · GeroScience · doi:10.1007/s11357-024-01296-9 · Cited by 42
Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins
Zanzoni, A., Spinelli, L., Braham, S., & Brun, C. (2017) · Microbiome · doi:10.1186/s40168-017-0307-1 · Cited by 39
Ikeda, T., Aida, M., Yoshida, Y., Matsumoto, S., Tanaka, M., Nakayama, J., Nagao, Y., Nakata, R., Oki, E., Akahoshi, T., et al. (2020) · British journal of surgery · doi:10.1002/bjs.11654 · Cited by 39
Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer
Zhang, X., Zhang, Y., Gui, X., Zhang, Z., Zhang, Z., Zhang, X., chen, W., Zhang, X., Wang, Y., Shang, Z., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104203 · Cited by 41
Wu, Z., Zhang, S., Li, L., Huang, Z., Huang, D., & Hu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887383 · Cited by 38
Boesch, M., Horvath, L., Baty, F., Pircher, A., Wolf, D. G. F., Spahn, S., Straussman, R., Tilg, H., & Brutsche, M. H. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005401 · Cited by 41
Lei, J., Xu, F., Deng, C., Nie, X., Zhong, L., Wu, Z., Li, J., Wu, X., He, S., & Chen, Y. (2023) · Cancer Science · doi:10.1111/cas.15787 · Cited by 38
Sinicrope, F. A., Chakrabarti, S., Laurent‐Puig, P., Huebner, L., Smyrk, T. C., Tabernero, J. M., Mini, E., Goldberg, R. M., Zaanan, A., Folprecht, G., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.016 · Cited by 39
Xu, Q., Lu, X., Li, J., Feng, Y., Tang, J., Zhang, T., Mao, Y., Lan, Y., Luo, H.-X., Zeng, L., et al. (2022) · Cancer Science · doi:10.1111/cas.15536 · Cited by 38
The Vaginal Microbiome is Associated with Endometrial Cancer Grade and Histology
Hakimjavadi, H., George, S. H. L., Taub, M., Dodds, L. V., Covarrubias, A. P. S., Huang, M. S., Pearson, J. M., Slomovitz, B. M., Kobetz, E. N., Gharaibeh, R. Z., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0075 · Cited by 38
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer
Alexander, J. L., Posma, J. M., Scott, A. J., Poynter, L., Mason, S., Dória, M. L., Herendi, L., Roberts, L., McDonald, J. A. K., Cameron, S. J. S., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01518-w · Cited by 40
The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities
Mima, K., Hamada, T., Inamura, K., Baba, H., Ugai, T., & Ogino, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2269623 · Cited by 39
Self-citationRight Versus Left Colon Cancer: Resectable and Metastatic Disease
Ghidini, M., Petrelli, F., & Tomasello, G. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0544-y · Cited by 37
Güven, D. C., Dızdar, Ö., Alp, A., Kıttana, F. N. A., Karakoç, D., Hamaloğlu, E., Laçin, Ş., Karakaş, Y., Kılıçkap, S., Hayran, M., et al. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0020 · Cited by 37
Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer
Lee, J. B., Kim, K., Cho, H. Y., Kim, D., Kim, W. K., Yong, D., Lee, H., Yoon, S. S., Han, D. H., Han, Y. D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98941-6 · Cited by 37
Male Tract Microbiota and Male Infertility
Grande, G., Graziani, A., Toni, L. D., Garolla, A., & Ferlin, A. (2024) · Cells · doi:10.3390/cells13151275 · Cited by 38
Lei, L., Kong, C., Li, J., Liu, G., Wei, J., Wang, G., Wang, Q., Yang, Y. P., Shi, D., Li, X., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01987-7 · Cited by 40
Silver, N. L., Dai, J., Kerr, T. D., Altemus, J. B., Garg, R. R., Simmons, H. L., Alban, T. J., Noël‐Romas, L., Makarov, V., Shih, D. J. H., et al. (2026) · Nature Cancer · doi:10.1038/s43018-025-01067-1 · Cited by 42
Colorectal carcinogenesis: an archetype of gut microbiota–host interaction
Alexander, J. L., Scott, A. J., Pouncey, A. L., Marchesi, J. R., Kinross, J. K., & TEARE, J. P. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.865 · Cited by 38
Host–MicroRNA–Microbiota Interactions in Colorectal Cancer
Yuan, C., Steer, C. J., & Subramanian, S. (2019) · Genes · doi:10.3390/genes10040270 · Cited by 38
Fusobacterium nucleatum, the communication with colorectal cancer
Luo, K., Zhang, Y., Xv, C., Ji, J., Lou, G., Guo, X., Chen, M., Zhang, Y., Wei, H., Guo, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108988 · Cited by 38
Microbiome as an Immunological Modifier
Kumar, M., Singh, P., Murugesan, S., Vétizou, M., McCulloch, J. A., Badger, J. H., Trinchieri, G., & Khodor, S. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_27 · Cited by 36
Nardelli, C., Granata, I., Nunziato, M., Setaro, M., Carbone, F., Zulli, C., Pilone, V., Capoluongo, E. D., Palma, G. D. D., Corcione, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910747 · Cited by 36
What is the future of Periodontal Medicine?
Fischer, R. G., Gomes‐Filho, I. S., da Cruz, S. S., Oliveira, V. B., Lira‐Junior, R., Scannapieco, F. A., & Rêgo, R. O. (2021) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2021.vol35.0102 · Cited by 42
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 37
Exploring the microbiota to better understand gastrointestinal cancers physiology
Panebianco, C., Potenza, A., Andriulli, A., & Pazienza, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1163 · Cited by 46
Colorectal cancer, radiotherapy and gut microbiota
Zhang, S., Wang, Q., Zhou, C., Chen, K., Chang, H., Xiao, W., & Gao, Y. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.01.16 · Cited by 36
Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
Brandi, G., & Frega, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112699 · Cited by 36
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer
Haruki, K., Kosumi, K., Hamada, T., Twombly, T. S., Väyrynen, J. P., Kim, S. A., Masugi, Y., Qian, Z. R., Mima, K., Baba, Y., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5381 · Cited by 38
Self-citationHARMONIES: A Hybrid Approach for Microbiome Networks Inference via Exploiting Sparsity
Jiang, S., Xiao, G., Koh, A. Y., Chen, Y., Yao, B., Li, Q., & Zhan, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00445 · Cited by 36
Velikova, T. V., Krastev, B. M., Lozenov, S., Gencheva, R., Peshevska-Sekulovska, M., Nikolaev, G., & Peruhova, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041754 · Cited by 38
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Haque, S., Raina, R., Afroze, N., Hussain, A., Alsulimani, A., Singh, V., Mishra, B. N., Kaul, S., & Kharwar, R. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.024 · Cited by 35
Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer
Ming, G., Yin, W., Zhang, J., Yin, J., Tang, X., Ling, J., Tang, Z., Yin, W., Wang, X., Ni, Q., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1119992 · Cited by 33
From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology
Bakir, I. A., Curtius, K., & Graham, T. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02368 · Cited by 33
Gut Microbiome in Health and Disease
Lavelle, A., & Hill, C. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.02.003 · Cited by 35
Tumour-associated and non-tumour-associated microbiota: Addendum
Flemer, B., Herlihy, M., O‘Riordain, M., Shanahan, F., & O’Toole, P. W. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1435246 · Cited by 34
Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites
Han, S., Jing, Z., Wu, Y., Wu, W., & Yang, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s268943 · Cited by 34
Differential Mucosal Microbiome Profiles across Stages of Human Colorectal Cancer
Zhang, M., Lv, Y., Hou, S., Liu, Y., Wang, Y., & Wan, X. (2021) · Life · doi:10.3390/life11080831 · Cited by 34
Choi, S.-J., Chung, J., Cho, M., Park, D., & Choi, S. S. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03154-0 · Cited by 35
Yamane, T., Kanamori, Y., Sawayama, H., Yano, H., Nita, A., Ohta, Y., Hinokuma, H., Maeda, A., Iwai, A., Matsumoto, T., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156802 · Cited by 33
Self-citationZhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 34
Chen, Q., Zhu, Y., Wang, K., Wang, X., Zhang, Y., Zhou, M., Du, J., Qu, X., Shi, Z., Zhang, Y., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101994 · Cited by 36
Masheghati, F., Asgharzadeh, M. R., Jafari, A., Masoudi, N., & Maleki, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122529 · Cited by 36
Human microbial ecology and the rising new medicine
Godoy‐Vitorino, F. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.56 · Cited by 35
Zhou, Z., Ge, S., Li, Y., Ma, W., Liu, Y., Hu, S., Zhang, R., Ma, Y., Du, K., Syed, A., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.596027 · Cited by 33
Shen, X., Li, J., Li, J., Zhang, Y., Li, X., Cui, Y., Gao, Q., Chen, X., Chen, Y., & Fang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661048 · Cited by 33
Fusobacterium nucleatum : a novel immune modulator in breast cancer?
Little, A., Tangney, M., Tunney, M. M., & Buckley, N. E. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.9 · Cited by 33
Zhao, L., Zhang, X., Zuo, T., & Yu, J. Q. (2017) · Engineering · doi:10.1016/j.eng.2017.01.012 · Cited by 35
Andrews, M. C., Reuben, A., Gopalakrishnan, V., & Wargo, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00946 · Cited by 33
Characteristics of the gut microbiome profile in obese patients with colorectal cancer
Shoji, M., Sasaki, Y., Abe, Y., Nishise, S., Yaoita, T., Yagi, M., Mizumoto, N., Kon, T., Onozato, Y., Sakai, T., et al. (2021) · JGH Open · doi:10.1002/jgh3.12529 · Cited by 34
Genomics and metagenomics of colorectal cancer
Ng, C., Li, H., Wu, W. K. K., Wong, S. H., & Yu, J. Q. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.06.04 · Cited by 34
Pan, H., Du, L., Li, W., Yang, Y., Zhang, Y., & Wang, C. (2020) · Research in Microbiology · doi:10.1016/j.resmic.2020.01.001 · Cited by 32
Eisele, Y., Mallea, P. M., Gigic, B., Stephens, W. Z., Warby, C. A., Buhrke, K., Lin, T., Boehm, J., Schrotz‐King, P., Hardikar, S. S., et al. (2021) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2021.02.007 · Cited by 32
The oral-gut-circulatory axis: from homeostasis to colon cancer
Tortora, S. C., Agurto, M. I. G., & Martello, L. A. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1289452 · Cited by 34
Miyasaka, T., Yamada, T., Uehara, K., Sonoda, H., Matsuda, A., Shinji, S., Ohta, R., Kuriyama, S., Yokoyama, Y., Takahashi, G., et al. (2024) · Cancer Science · doi:10.1111/cas.16088 · Cited by 36
Gut Microbiome–Colorectal Cancer Relationship
Yadav, D., Sainatham, C., Filippov, E., Kanagala, S. G., Ishaq, S. M., & Jayakrishnan, T. (2024) · Microorganisms · doi:10.3390/microorganisms12030484 · Cited by 33
A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy
Han, H., Zhang, Y., Tang, H., Zhou, T., & Khan, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073896 · Cited by 33
Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma
Mima, K., Sakamoto, Y., Kosumi, K., Ogata, Y., Miyake, K., Hiyoshi, Y., Ishimoto, T., Iwatsuki, M., Baba, Y., Iwagami, S., et al. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.11.005 · Cited by 33
Self-citationThe Role of Fusobacterium nucleatum in Colorectal Carcinogenesis
Datorre, J. G., de Carvalho, A. C., Guimarães, D. P., & Reis, R. M. (2020) · Pathobiology · doi:10.1159/000512175 · Cited by 32
Wang, Z., Guo, K., Liu, Y., Huang, C., & Wu, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.10.004 · Cited by 33
Borgognone, A., Serna, G., Noguera-Julián, M., Alonso, L., Parera, M., Català‐Moll, F., Sanchez, L. R., Fasani, R., Paredes, R., & Nuciforo, P. G. (2021) · Cancers · doi:10.3390/cancers13215421 · Cited by 34
Combination gut microbiota modulation and chemotherapy for orthotopic colorectal cancer therapy
Chen, Z., Li, J.-L., Pan, P., Bao, P., Zeng, X., & Zhang, X. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101329 · Cited by 31
Jia, F., Yu, Q., Wang, R., Zhao, L., Yuan, F., Guo, H., Shen, Y., & He, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021469 · Cited by 32
Leppänen, J., Helminen, O., Huhta, H. I., Kauppila, J. H., Isohookana, J., Haapasaari, K., Lehenkari, P. P., Saarnio, J., & Karttunen, T. J. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2087-1 · Cited by 31
Microbiota as the unifying factor behind the hallmarks of cancer
Benešová, I., Křížová, Ľ., & Kverka, M. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05244-6 · Cited by 34
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies
Krieger, M., Guo, M., & Merritt, J. L. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2415490 · Cited by 33
Exploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications
Chen, G., Ren, Q., Zhong, Z., Li, Q., Huang, Z., Zhang, C., Yuan, H., Feng, Z., Chen, B., Wang, N., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1431747 · Cited by 34
Rastogi, Y. R., Saini, A. K., Thakur, V. K., & Saini, R. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093212 · Cited by 32
The Microbiome and Its Implications in Cancer Immunotherapy
Choudhry, H. (2021) · Molecules · doi:10.3390/molecules26010206 · Cited by 31
Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies
Zhang, X., Zhang, W., & Cao, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.629390 · Cited by 30
Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells
Kim, Y. J., Kim, B. K., Park, S. J., & Kim, J. H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4879 · Cited by 31
Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy
Wang, D., Gu, Y., Yan, X., Huo, C.-D., Wang, G., Zhao, Y., Teng, M., & Li, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.844260 · Cited by 30
Kovaleva, O. V., Алексеевна, П. П., Sorokin, M., Mochalnikova, V. V., Kataev, V., Khlopko, Y. A., Plotnikov, A. O., Stilidi, I. S., Кушлинский, Н. Е., & Gratchev, A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10071516 · Cited by 30
Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients
Tran, H. N. H., Thu, T. N. H., Nguyen, P. H., Vo, C. N., Doan, K. V., Minh, C. N. N., Nguyễn, N. T., Ta, V. N. D., Vu, K. A., Hua, T. D., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00351-7 · Cited by 31
The Impact of the Gut Microbiome on Colorectal Cancer
Maisonneuve, C., Irrazábal, T., Martín, A., Girardin, S. E., & Philpott, D. J. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050240 · Cited by 30
Characterization of Mucosal Dysbiosis of Early Colonic Neoplasia
Hong, B., Ideta, T., Lemos, B. S., Igarashi, Y., Tan, Y., DiSiena, M., Mo, A., Birk, J. W., Forouhar, F., Devers, T. J., et al. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0101-6 · Cited by 33
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Araujo, D. V., Watson, G. A., Oliva, M., Heirali, A., Coburn, B., Spreafico, A., & Siu, L. L. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102125 · Cited by 29
Rauth, S., Malafa, M. P., Ponnusamy, M. P., & Batra, S. K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.005 · Cited by 29
Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway
Lu, P., Xu, M., Xiong, Z., Zhou, F., & Wang, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185766 · Cited by 31
Sharma, A. (2020) · Current Oral Health Reports · doi:10.1007/s40496-020-00254-6 · Cited by 29
Metadata
- Authors
- Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A. D., Giannakis, M., Bullman, S., Milner, D. A., Baba, H., Giovannucci, E. L., Garraway, L. A., Freeman, G. J., Dranoff, G., Garrett, W. S., Huttenhower, C., Meyerson, M., Meyerhardt, J. A., Chan, A. T., Fuchs, C. S., & Ogino, S.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Kumamoto University (JP)
- Corresponding author
- Ogino, Shuji
- ORCID
- Mima, Kosuke
- Nishihara, Reiko
- Qian, Zhi Rong
- Cao, Yin
- Sukawa, Yasutaka
- Nowak, Jonathan A
- Yang, Juhong
- Dou, Ruoxu
- Masugi, Yohei
- Song, Mingyang
- Kostic, Aleksandar D
- Giannakis, Marios
- Bullman, Susan
- Milner, Danny A
- Baba, Hideo
- Giovannucci, Edward L
- Garraway, Levi A
- Freeman, Gordon J
- Dranoff, Glenn
- Garrett, Wendy S
- Huttenhower, Curtis
- Meyerson, Matthew
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Fuchs, Charles S
- Ogino, Shuji
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-08-26
- Volume
- 65
- Issue
- 12
- Pages
- 1973-1980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4769120
- OpenAlex
- W2199896469
- Cited by
- 1,080
- References
- 53
- Citations by year
- 2026: 108 · 2025: 116 · 2024: 131 · 2023: 119 · 2022: 141 · 2021: 140 · 2020: 105 · 2019: 71 · 2018: 64 · 2017: 47 · 2016: 34 · 2015: 4
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR001100)
- National Cancer Institute (P50CA127003, R01CA151993, R01CA118553, R01CA137178, R35CA197735, P01CA087969, R01CA169141, K07CA122826, P01CA055075, UM1CA186107, UM1CA167552, K07CA190673, R01CA154426)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, rectal cancer, colon cancer, prognosis, colorectal cancer-specific mortality, tumor microbiome, microsatellite instability, CpG island methylator phenotype, BRAF mutation, prognostic factors, gut microbiota, antitumor immunity
- MeSH terms
- Aged, Carcinoma, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Phenotype, Prognosis, Prospective Studies, Research Design, Biomarkers, Tumor, Colorectal Neoplasms, Databases, Factual, Proto-Oncogene Proteins p21(ras), Fusobacterium nucleatum, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins B-raf, Kaplan-Meier Estimate, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
